The cost of the offset is not even itemized in the FMS offer, and if the client wants to discuss or simply to know the cost of the offset, the client must speak directly with the Contractor and not with DSCA.
The stock was on track to open at $4.00, below its previous record low close of $5.30 on Dec. 11, 2015. As part of FXCM's settlement with the CFTC, the company will sell its U.S. customer accounts, which had generated about $48 million in revenue in 2016, to Gain Capital Holdings Inc. for an undisclosed amount.
(TMFTypeoh). Jul 30, 2015 at 5:17PM. What: Shares of Genocea Biosciences (NASDAQ:GNCA), a biotech company with a focus on vaccines and immunotherapies, fell more than 10% today before moderating back to a 7% loss after the company announced the pricing of its recently announced $50 million public offering.o What: Genocea is selling 3.85 million shares of its common stock at a price of $13 per share, plus it is granting its underwriters the option to purchase an additional 577,500 shares at the same price.